Sign in
Back
184 - A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 Plus Standard of Care (SOC) Versus Placebo Plus SOC in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (E-CELERATE; NCT05181540): Trial in Progress
Journal article   Peer reviewed

184 - A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 Plus Standard of Care (SOC) Versus Placebo Plus SOC in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (E-CELERATE; NCT05181540): Trial in Progress

Michael Scordo, Geoffrey Shouse, Luke Mountjoy, Jordan Gauthier, Carolyn Mulroney, Bhagirathbhai Dholaria, Scott D. Rowley, Jeremy Pantin, Zachariah DeFilipp, Monica Mead, …
Transplantation and cellular therapy, Vol.29(2), pp.S146-S147
2023-02
DOI: https://doi.org/10.1016/S2666-6367(23)00253-1
Appears in  Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details